DK1567195T3 - Dendrimerkonjugater til selektiv opløsning af proteinaggregater - Google Patents
Dendrimerkonjugater til selektiv opløsning af proteinaggregaterInfo
- Publication number
- DK1567195T3 DK1567195T3 DK03775106.2T DK03775106T DK1567195T3 DK 1567195 T3 DK1567195 T3 DK 1567195T3 DK 03775106 T DK03775106 T DK 03775106T DK 1567195 T3 DK1567195 T3 DK 1567195T3
- Authority
- DK
- Denmark
- Prior art keywords
- dendrimer
- protein
- dendrimer conjugates
- conjugates
- solubilising
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G83/00—Macromolecular compounds not provided for in groups C08G2/00 - C08G81/00
- C08G83/002—Dendritic macromolecules
- C08G83/003—Dendrimers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nanotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Crystallography & Structural Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Polymers & Plastics (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200201828 | 2002-11-26 | ||
| PCT/DK2003/000812 WO2004047869A1 (en) | 2002-11-26 | 2003-11-26 | Dendrimer conjugates for selective of protein aggregates |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1567195T3 true DK1567195T3 (da) | 2011-02-14 |
Family
ID=32337945
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK03775106.2T DK1567195T3 (da) | 2002-11-26 | 2003-11-26 | Dendrimerkonjugater til selektiv opløsning af proteinaggregater |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20060127350A1 (da) |
| EP (1) | EP1567195B1 (da) |
| AT (1) | ATE485839T1 (da) |
| AU (1) | AU2003283205A1 (da) |
| DE (1) | DE60334726D1 (da) |
| DK (1) | DK1567195T3 (da) |
| WO (1) | WO2004047869A1 (da) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7153905B2 (en) * | 2003-03-21 | 2006-12-26 | The General Hospital Corporation | Hyperbranched dendron and methods of synthesis and use thereof |
| DE102004040119A1 (de) * | 2004-08-18 | 2006-04-27 | Heinrich-Heine-Universität Düsseldorf | Mittel zur Therapie und Prävention von Prionenerkrankungen |
| WO2006102484A2 (en) * | 2005-03-21 | 2006-09-28 | Anp Technologies, Inc. | Symmetrically branched polymer conjugates and microarray assays |
| GR1006666B (el) * | 2006-07-21 | 2010-01-19 | Εθνικο Κεντρο Ερευνας Φυσικων Επιστημων (Εκεφε) "Δημοκριτος" | Μοριακοι δενδριτικοι φορεις με προσαρμοζομενη/μεταβαλλομενη διαλυτοτητα και συμπληρωματικοτητα προς μεμβρανικους υποδοχεις |
| IL178645A0 (en) * | 2006-10-16 | 2007-02-11 | Ariel University Res And Dev C | Dendrimeric platform for controlled release of drugs |
| WO2011001657A1 (ja) | 2009-07-01 | 2011-01-06 | 独立行政法人科学技術振興機構 | ポリイオンデンドリマー、及びそれよりなるハイドロゲル |
| WO2012065082A1 (en) * | 2010-11-11 | 2012-05-18 | Massachusetts Institute Of Technology | Dendrimer-based excipients for the attentuation of protein aggregation |
| CA2824063C (en) * | 2011-01-09 | 2020-02-18 | Anp Technologies, Inc. | Hydrophobic molecule-induced branched polymer aggregates and their use |
| US20190015350A1 (en) | 2013-02-05 | 2019-01-17 | Anp Technologies, Inc. | Nanoparticles Containing a Taxane and their Use |
| US8883239B2 (en) | 2013-02-26 | 2014-11-11 | Universidad De Talca | Clarification and selective binding of phenolic compounds from liquid foodstuff or beverages using smart polymers |
| CA3024333A1 (en) * | 2016-05-26 | 2017-11-30 | University Of Idaho | A system and method for water treatment |
| JP7136790B2 (ja) | 2017-02-17 | 2022-09-13 | ブリストル－マイヤーズ スクイブ カンパニー | アルファ－シヌクレインに対する抗体およびその使用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3214366A (en) * | 1964-07-20 | 1965-10-26 | Standard Oil Co | Hydrocarbon conversion process |
| US4587329A (en) * | 1984-08-17 | 1986-05-06 | The Dow Chemical Company | Dense star polymers having two dimensional molecular diameter |
| ATE277640T1 (de) * | 1994-03-07 | 2004-10-15 | Dow Chemical Co | Bioaktive und/oder gezielte dendrimere-konjugate enthaltend genetisches material |
| US6719988B2 (en) * | 1997-02-21 | 2004-04-13 | The Regents Of The University Of California | Antiseptic compositions for inactivating prions |
| BR0011055A (pt) * | 1999-06-01 | 2002-05-21 | Univ California | Método de esterilização |
| PT1251737E (pt) * | 2000-01-31 | 2005-08-31 | Univ California | Composicoes tratadas para inactivar proteinas infecciosas |
| MXPA03011455A (es) * | 2001-06-22 | 2004-04-05 | Hoffmann La Roche | Complejo soluble que comprende glucoproteina de superficie retroviral. |
| KR20050111586A (ko) * | 2003-02-13 | 2005-11-25 | 내셔널 센터 포 사이언티픽 리서치 데모크리토스 | 드러그 및 유전자 전달 시스템으로서의 다기능의 덴드리머및 다중결합된 폴리머 |
-
2003
- 2003-11-26 DK DK03775106.2T patent/DK1567195T3/da active
- 2003-11-26 AT AT03775106T patent/ATE485839T1/de not_active IP Right Cessation
- 2003-11-26 AU AU2003283205A patent/AU2003283205A1/en not_active Abandoned
- 2003-11-26 US US10/536,629 patent/US20060127350A1/en not_active Abandoned
- 2003-11-26 DE DE60334726T patent/DE60334726D1/de not_active Expired - Lifetime
- 2003-11-26 EP EP03775106A patent/EP1567195B1/en not_active Expired - Lifetime
- 2003-11-26 WO PCT/DK2003/000812 patent/WO2004047869A1/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2004047869A1 (en) | 2004-06-10 |
| ATE485839T1 (de) | 2010-11-15 |
| EP1567195A1 (en) | 2005-08-31 |
| EP1567195B1 (en) | 2010-10-27 |
| US20060127350A1 (en) | 2006-06-15 |
| DE60334726D1 (de) | 2010-12-09 |
| AU2003283205A1 (en) | 2004-06-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1114916T1 (el) | Μεθοδοι | |
| CY1120926T1 (el) | Συνθεσεις και kit για την απομακρυνση ερεθιστικων ενωσεων απο σωματικες επιφανειες | |
| EA200900802A1 (ru) | Способы и композиции для лечения амилоидных заболеваний | |
| EA200600078A1 (ru) | Способы и композиции для лечения амилоидных заболеваний | |
| CY1112055T1 (el) | Συνθεσεις και μεθοδοι για την διαγνωση και θεραπευτικη αγωγη ογκου πνευμονα | |
| CY2014028I2 (el) | Ενωσεις, φαρμακοτεχνικες μορφες και μεθοδοι θεραπειας ή αποτροπhς ροδοχρωμης ακμης | |
| ATE507839T1 (de) | Kombinationstherapie | |
| CY1112862T1 (el) | Θραυσματα μονοσθενους αντισωματος χρησιμα ως θεραπευτικα | |
| CY1109240T1 (el) | Συνδυασμος που περιλαμβανει βαλσαρτανη, αμλοδιπινη και υδροχλωροθειαζιδιο | |
| ATE503461T1 (de) | Pharmazeutische zusammensetzungen zur behandlung von asthma | |
| CY1115745T1 (el) | Συνθεσεις και μεθοδοι για αντιμετωπιση ή προληψη σχετιζομενης με οξαλικα νοσου | |
| CY1111050T1 (el) | Φωσφονικα, μονοφωσφοναμιδικα, διφωσφοναμιδικα για την αγωγη των ιϊκων παθησεων | |
| CY1111225T1 (el) | Νεα πεπτιδια ως αναστολεις πρωτεασης νs3-σερινης ιου ηπατiτιδας c | |
| DK1567195T3 (da) | Dendrimerkonjugater til selektiv opløsning af proteinaggregater | |
| DE60228103D1 (de) | Chemische verbindungen | |
| CY1111212T1 (el) | Θειικες ενωσεις ως αναστολεις της πρωτεασης σερινης ns3 του ιου της ηπατιτιδας γ | |
| BR0315157A (pt) | Métodos de tratar doença de alzheimer empregando-se anticorpos direcionados contra peptìdeo beta amilóide e composições deste | |
| DK1594833T3 (da) | 1-phenylalkancarboxylsyrederivater til behandling af neurodegenerative sygdomme | |
| ATE267830T1 (de) | Als cox-hemmer verwendbare sulfonylphenylpyrazol- verbindungen | |
| DE60137337D1 (de) | Vorbeugende und therapeutsche monoklonale antikörper gegen vacciniavirusantigene | |
| ATE319439T1 (de) | Mittel zur behandlung von erkrankungen des tracheo-bronchialtraktes, insbesondere der copd | |
| CY1107439T1 (el) | Μεθοδοι προληψης και θεραπειας μολυνσης απο ιο του γενους flavivirus σε ζωα | |
| EA200702212A1 (ru) | Способ лечения или профилактики разрушения кости или остеопороза | |
| EA200600128A1 (ru) | Способ уничтожения раковых клеток (варианты), фармацевтическое средство (варианты) и набор для его осуществления | |
| DE60115647D1 (de) | Verbindungen zur behandlung von beeinträchtigten fundischen entspannung |